Molecular diagnosis of non-syndromic hearing loss patients using a stepwise approach

Abstract Hearing loss is one of the most common birth disorders in humans, with an estimated prevalence of 1–3 in every 1000 newborns. This study investigates the molecular etiology of a hearing loss cohort using a stepwise strategy to effectively diagnose patients and address the challenges posed b...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jing Wang, Jiale Xiang, Lisha Chen, Hongyu Luo, Xiuhua Xu, Nan Li, Chunming Cui, Jingjing Xu, Nana Song, Jiguang Peng, Zhiyu Peng
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/5afb01c858dc4465ac1c61be42c42571
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5afb01c858dc4465ac1c61be42c42571
record_format dspace
spelling oai:doaj.org-article:5afb01c858dc4465ac1c61be42c425712021-12-02T14:03:45ZMolecular diagnosis of non-syndromic hearing loss patients using a stepwise approach10.1038/s41598-021-83493-62045-2322https://doaj.org/article/5afb01c858dc4465ac1c61be42c425712021-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-83493-6https://doaj.org/toc/2045-2322Abstract Hearing loss is one of the most common birth disorders in humans, with an estimated prevalence of 1–3 in every 1000 newborns. This study investigates the molecular etiology of a hearing loss cohort using a stepwise strategy to effectively diagnose patients and address the challenges posed by the genetic heterogeneity and variable mutation spectrum of hearing loss. In order to target known pathogenic variants, multiplex PCR plus next-generation sequencing was applied in the first step; patients which did not receive a diagnosis from this were further referred for exome sequencing. A total of 92 unrelated patients with nonsyndromic hearing loss were enrolled in the study. In total, 64% (59/92) of the patients were molecularly diagnosed, 44 of them in the first step by multiplex PCR plus sequencing. Exome sequencing resulted in eleven diagnoses (23%, 11/48) and four probable diagnoses (8%, 4/48) among the 48 patients who were not diagnosed in the first step. The rate of secondary findings from exome sequencing in our cohort was 3% (2/58). This research presents a molecular diagnosis spectrum of 92 non-syndromic hearing loss patients and demonstrates the benefits of using a stepwise diagnostic approach in the genetic testing of nonsyndromic hearing loss.Jing WangJiale XiangLisha ChenHongyu LuoXiuhua XuNan LiChunming CuiJingjing XuNana SongJiguang PengZhiyu PengNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jing Wang
Jiale Xiang
Lisha Chen
Hongyu Luo
Xiuhua Xu
Nan Li
Chunming Cui
Jingjing Xu
Nana Song
Jiguang Peng
Zhiyu Peng
Molecular diagnosis of non-syndromic hearing loss patients using a stepwise approach
description Abstract Hearing loss is one of the most common birth disorders in humans, with an estimated prevalence of 1–3 in every 1000 newborns. This study investigates the molecular etiology of a hearing loss cohort using a stepwise strategy to effectively diagnose patients and address the challenges posed by the genetic heterogeneity and variable mutation spectrum of hearing loss. In order to target known pathogenic variants, multiplex PCR plus next-generation sequencing was applied in the first step; patients which did not receive a diagnosis from this were further referred for exome sequencing. A total of 92 unrelated patients with nonsyndromic hearing loss were enrolled in the study. In total, 64% (59/92) of the patients were molecularly diagnosed, 44 of them in the first step by multiplex PCR plus sequencing. Exome sequencing resulted in eleven diagnoses (23%, 11/48) and four probable diagnoses (8%, 4/48) among the 48 patients who were not diagnosed in the first step. The rate of secondary findings from exome sequencing in our cohort was 3% (2/58). This research presents a molecular diagnosis spectrum of 92 non-syndromic hearing loss patients and demonstrates the benefits of using a stepwise diagnostic approach in the genetic testing of nonsyndromic hearing loss.
format article
author Jing Wang
Jiale Xiang
Lisha Chen
Hongyu Luo
Xiuhua Xu
Nan Li
Chunming Cui
Jingjing Xu
Nana Song
Jiguang Peng
Zhiyu Peng
author_facet Jing Wang
Jiale Xiang
Lisha Chen
Hongyu Luo
Xiuhua Xu
Nan Li
Chunming Cui
Jingjing Xu
Nana Song
Jiguang Peng
Zhiyu Peng
author_sort Jing Wang
title Molecular diagnosis of non-syndromic hearing loss patients using a stepwise approach
title_short Molecular diagnosis of non-syndromic hearing loss patients using a stepwise approach
title_full Molecular diagnosis of non-syndromic hearing loss patients using a stepwise approach
title_fullStr Molecular diagnosis of non-syndromic hearing loss patients using a stepwise approach
title_full_unstemmed Molecular diagnosis of non-syndromic hearing loss patients using a stepwise approach
title_sort molecular diagnosis of non-syndromic hearing loss patients using a stepwise approach
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/5afb01c858dc4465ac1c61be42c42571
work_keys_str_mv AT jingwang moleculardiagnosisofnonsyndromichearinglosspatientsusingastepwiseapproach
AT jialexiang moleculardiagnosisofnonsyndromichearinglosspatientsusingastepwiseapproach
AT lishachen moleculardiagnosisofnonsyndromichearinglosspatientsusingastepwiseapproach
AT hongyuluo moleculardiagnosisofnonsyndromichearinglosspatientsusingastepwiseapproach
AT xiuhuaxu moleculardiagnosisofnonsyndromichearinglosspatientsusingastepwiseapproach
AT nanli moleculardiagnosisofnonsyndromichearinglosspatientsusingastepwiseapproach
AT chunmingcui moleculardiagnosisofnonsyndromichearinglosspatientsusingastepwiseapproach
AT jingjingxu moleculardiagnosisofnonsyndromichearinglosspatientsusingastepwiseapproach
AT nanasong moleculardiagnosisofnonsyndromichearinglosspatientsusingastepwiseapproach
AT jiguangpeng moleculardiagnosisofnonsyndromichearinglosspatientsusingastepwiseapproach
AT zhiyupeng moleculardiagnosisofnonsyndromichearinglosspatientsusingastepwiseapproach
_version_ 1718392081021403136